SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Oct 15, 2009

AGENUS INC (AGEN) (CIK 0001098972)
Date: Oct. 15, 2009 · CIK: 0001098972 · Accession: 0000000000-09-058182

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-29089

Date

October 15, 2009

Author

Jeffrey Riedler, Assistant Director

Form

UPLOAD

Company

AGENUS INC (AGEN) (CIK 0001098972)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 October 15, 2009 Garo H. Armen, Ph.D. President and Chief Executive Officer Antigenics Inc. 162 Fifth Avenue, Suite 900 New York, New York 10010

Re: Antigenics Inc. Form 10-K for the Fiscal Year Ended December 31, 2008 Filed March 16, 2009 File Number 000-29089

Dear Dr. Armen:

We have completed our review of your Form 10-K and related filings and have no further comments at this time.

Sincerely,
Jeffrey Riedler, Assistant Director

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                    October 15, 2009 Garo H. Armen, Ph.D.  President and Chief Executive Officer  Antigenics Inc.  162 Fifth Avenue, Suite 900  New York, New York 10010

 Re: Antigenics Inc.
Form 10-K for the Fiscal Year Ended December 31, 2008 Filed March 16, 2009 File Number 000-29089

Dear Dr. Armen:

 We have completed our review of your Form 10-K and related filings and
have no further comments at this time.

Sincerely,

 Jeffrey Riedler,  Assistant Director

SecProbe.io